title: Reversible anorexia and rapid weight loss associated with neuroleptic administration in Alzheimer's disease.
abstract: Weight loss and malnutrition despite adequate dietary intake has been reported to be part of the clinical course in advanced dementia of the Alzheimer type. We present a case of reversible weight loss associated with neuroleptic use in a patient with Alzheimer's disease and discuss a possible pathophysiological basis for the weight loss.
authors.affiliation: Department of Psychiatry, Yale University, New Haven, Connecticut.
authors.forename: R M
authors.initials: RM
authors.lastname: Rohrbaugh
authors.forename: A P
authors.initials: AP
authors.lastname: Siegal
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D000855:Anorexia / Q000139:chemically induced*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D001068:Feeding and Eating Disorders / Q000139:chemically induced*; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D010546:Perphenazine / Q000009:adverse effects; D015431:Weight Loss / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D010546:Perphenazine; D006220:Haloperidol; D005476:Fluphenazine